The immuno-pharmacological profile of a novel immunosuppressive agent, produced by a streptomycete, is presented here. Weproceeded to test the effect of the agent on various in vitro immunesystems. It showed that mixed lymphocyte reaction, cytotoxic T cell generation, the production of T cell-derived soluble mediators such as interleukin 2 (IL-2), interleukin 3 and gamma-interferon and the expression of the IL-2 receptor were suppressed by this agent. The IC50 values of FK-506 and ciclosporin (CS) in all tests were approximately 0.1 nM and 10 nM, respectively. Therefore, the novel agent, FK-506 suppressed in vitro immunesystems at about hundred times lower concentration than CS.
During the course of our research program for discovery of immunosuppressivesubstances in the natural products, we found a new immunosuppressant, FK-506from the fermentation broth of a strain of Streptomyces. The chemical structure of this agent belongs to macrolides. It is water insoluble and soluble in alcohol. The immunosuppressive effect of this agent was more highly potent than ciclosporin (CS) in vitro and in vivo.i:> CS, a fungal metabolite, is a powerful immunosuppressive agent that may represent one of the most important therapeutic advances in clinical organ transplantation in recent years.2>3) By many investigator's results obtained from in vitro studies and animal models, at least two well established mechanisms have been advanced to explain the effects of CS; first, CS inhibits the release of lymphokines in vitro, especially interleukin 2 (IL-2);4>5) secondly, CS therapy prevents clonal expansion of helper and cytotoxic T cells6'7) and semi-selectively spares suppressor cells.8»9) In this paper, the immuno-pharmacological profile of the new immunosuppressive agent, FK-506, is presented in in vitro studies compared with CS.
Materials and Methods

Mice
Specific pathogen free (SPF) BALB/Cand C57BL/6 mice (female, 6~7 weeks old) were obtained from Charles River Japan Inc. (Kanagawa, Japan). SPF C3H/HeJ mice (male, 6-7 weeks old) were obtained from the Jackson Laboratories (Bar Harbor, ME, U.S.A.). They were maintained under SPF conditions until used.
Medium RPMI 1640 medium, Eagle's minimum essential medium (EMEM), Dulbecco's modified 1 257 Eagle's medium(DMEM) and McCoy's medium5A were purchased from Flow Laboratories (Rockville, MD, U.S.A.). Fetal calf serum (FCS) was purchased from Gibco (Gland Island, NY, U.S.A.). Unless otherwise indicated, complete medium comprised RPMI1640, EMEM or DMEM, supplemented with 10% heat-inactivated FCS, 2 x 10~6 m sodium bicarbonate, 5 x 10~5 m 2-mercaptoethanol (2ME), 50 u/ml benzylpenicillin and 50 jug/ml streptomycin.
Drugs CS and prednisolone (PRD) were dissolved in ethanol at 1 mMand further diluted in mediumand added to the cultures. CS was a generous gift from Sandoz Ltd., Biological and Medical Research (Basel, Switzerland) . PRD was obtained from Sigma Chemical Co. (MO, U.S.A.). Cells C57BL/6 thymoma EL4, AKR/J thymoma BW5147, DBA/2 mastocytoma P815 and human T cell leukemia Molt 4 were maintained in RPMI1640 complete medium. L929, a murine fibrosarcoma cell line was maintained as an adherent line in vitro by serial passage in DMEM complete mediumusing trypsinization (trypsin 0.25%, Gibco). CTLL-2 cells, IL-2 dependent murine T cell line were maintained in DMEM complete medium supplemented with 20%AOFSsupernatant stimulating with concanavalin A (Con A) (10^g/ml). AOFScells were maintained in DMEM complete medium. WEHI-3cells, IL-3 producing cell line were maintained in RPMI1640 complete medium. FDCP-2 cells, IL-3 dependent line were maintained in RPMI1640 complete medium supplemented with 20% WEHI-3 supernatant.
Preparation of Spleen Cells
The spleen obtained from BALB/Cand C57BL/6mice was teased into single cell suspensions and filtered through nylon mesh. The cell suspension was freed of erythrocytes by treatment with ammoniumchloride buffer (ACKbuffer) and washed three times. Cell preparation was finally resuspended in RPMI1640 complete medium.
Preparation of Peripheral Blood Lymphocytes (PBL) Human PBL were obtained from healthy adult donors. The PBL were isolated by Ficoll-Paque (Pharmacia Fine Chemicals, Piscataway, NJ, U.S.A.) density centrifugation. The collected cells were washed three times and filtered through nylon mesh. Cell preparation was finally resuspended in RPMI 1640 complete medium.
Mouse Mixed Lymphocyte Reaction (MLR)
The mouse bulk MLRwas performed in 24-well tissue culture plates (Corning Glass Works, Corning, NY, U.S.A.), with each well containing 5 x 106 C57BL/6 spleen cells (responder cells, H-2b), 5 x 106 mitomycin C-treated (25 /*g/ml mitomycin C at 37°C for 30 minutes and washed three times with RPMI 1640 medium) BALB/Cspleen cells (stimulator cells, H-2d) in 2 ml RPMI1640 complete medium. The cells were incubated at 37°C in a humidified atmosphere of 5%CO2 -95% air.
Human MLR The human MLRtest was established by using normal human PBLResponder lymphocytes (2.5 x 105 cells) were co-cultured with an equal number of mitomycin C treated stimulator lymphocytes in 0.2 ml RPMI1640 complete medium. The cells were incubated at 37°C in a humidified atmosphere of 5% CO2-95% air for 96 hours. The cultures were pulsed with 0.5^Ci of [3H]thymidine ([3H]TdR, specific activity, 6.7 Ci/nmol; New England Nuclear, Boston, MA, U.S.A.) during the final 4 hours and harvested onto glass fiber filter paper with a micro-harvestor (Bellco. Glass Inc., Vineland, NJ, U.S.A.). The filter papers were dried and processed for liquid scintillation counting.
Humanbulk MLRwas performed in 24-well tissue culture plates in a volume of 2 ml/well. Therefore, 2.5 x lO6 responding lymphocytes were co-cultured with an equal number of mitomycin Ctreated stimulating lymphocytes in RPMI 1640 complete medium.
Cytotoxic Assay The cytotoxicity tests, used EL4 thymoma, BW5147 thymomaand Molt 4 lyrnphoma, were per- Colony Forming Unit per Culture (cfu-C) Assay
The marrow plugs from C3H/HeJ mice were flushed out of femurs and dissociated by repeated aspiration until a single cell suspension was obtained. Bone marrowmononuclear cells (1.5 x lO5) were plated into 6-well tissue culture plates (Nunclon, Denmark) in 1.0 ml of 0.45 % Bacto agar (Difco Laboratories, Detroit, MI, U.S.A.) culture medium that included McCoy's medium 5A supplied with additional essential and nonessential amino acids, vitamins, glutamine, serine, asparagine, and sodium pyruvate, and contained 15 % heat inactivated FCS and 10% L929 culture supernatants as colony-stimulating factors. The cultures were incubated at 37°C in a humidified atmosphere of 5 % CO2-95%air and scored for colonies after 7 days of incubation. The numberof colonies on the plates was determined with a dissecting microscope. Aggregates of 40 or more cells were defined as colonies.
L929 Supernatants Preparation: L929 cells were grown as adherent monolayers in tissue culture flasks (F75, Corning) in 25 ml DMEM complete medium. Cells were seeded at 105 per flask, and the supernatants were collected and centrifuged 7 days later and filtered through a Millex 0.22 ptm filter (Millipore Corp., Bed ford, MA, U.S.A.).
IL-2 Assay IL-2 activity was measured according to the method described by Gillis and Smith.10) Briefly, the IL-2 dependent CTLL-2 cell line was used to quantitate IL-2 activity. CTLL-2 cells, 4xlO3, were cultured in flat-bottom microtiter plates at 37°C for 24 hours with various dilutions of IL-2 containing supernatants from bulk MLR(0, 24, 48, 72 and 96 hours) in 0.1 ml of DMEMcomplete medium.
[3H]TdR uptake was measured by pulsing cultures with 0.5^Ci of [3H]TdR for 6 hours. The unit value was calculated by dilution analysis of test sample and was compared with a laboratory standard preparation in which 100 u is equivalent to the amount of IL-2 necessary to achieve 50% proliferation of CTLL-2 cells. The laboratory standard preparation was supernatant from culturing AOFScells (IL-2 producing hybridoma). AOFScells (5 x 105/nil) were incubated with Con A (10 /^g/ml) in tissue culture flasks (F75, Corning) in a volume of 30 ml DMEM complete mediumfor 24 hours, at which time the supernatants were harvested, centrifuged to remove the cells, and filtered through a filter (0.22 jLim).
IL-3 Assay
The IL-3 dependent FDC-P2 cell line was used to quantitate IL-3 activity. FDC-P2 cells, 1 x 104, were cultured in flat-bottom microtiter plates at 37°C for 24 hours with various dilutions of IL-3 containing supernatants from bulk MLR(0, 24, 48, 72 and 96 hours) in 0.1 ml of RPMI 1640 complete medium.
[3H]TdR uptake was measured by pulsing cultures with 0.5 jbtCi of [3H]TdR for 4 hours. The unit value was calculated by dilution analysis of test samples and was compared with a laboratory standard preparation in which 100 u is equivalent to the amount of IL-3 necessary to achieve 50 % proliferation of FDC-P2 cells. The laboratory standard preparation was supernatant from culturing WEHI-3 cells (IL-3 producing cell line). WEHI-3 cells (1 x 106/ml) were incubated in tissue culture flasks (F75, Corning) in a volume of 30 ml RPMI 1640 complete medium for 48 hours, at which time the supernatant were harvested, centrifuged to removethe cells, and filtered through a Millex 0.22^m filter.
Gamma-interferon (IFN-f) Assay
IFN-p liters were quantitated by a conventional cytopathic effect reduction assay using L929 cells and vesicular stomatitis virus (VSV)as the challenge virus. The culture supernatants were serially diluted in flat-bottom microtiter plates in a volume of 50^I/well. To this were seeded 50 [A of L-cells (4.5 x 105 cells/ml) in EMEMsupplemented with 10% FCS. After 24 hours, the cultures were drained and the monolayers in each well were challenged with 50 /4 of 100 TCID50 (50% tissue cultureinfective doses) of VSVin serum-free EMEM. About 24 hours later, when the control wells which had not received IFN showed a complete cytopathic effect, the cells were stained with 50 /4 of neutral red (125 jug/ml) in EMEMwith 5% FCS for 90 minutes at 37°C. To quantitate the cytopathic effect, the dye was eluted with 50% ethanol in 0.1 m NaH2PO4-2H2O(pH 4.5), according to the method of^inter10 with minor modifications. The absorbance of each well was read on a twowavelength microplate photometer (Model MTP-22; Corona Electric Co., Ltd., Katsuta, Japan) at 550 nm. The percentage of dye uptake was calculated for each well relative to the average virus (0%) and average cell (100%) control. The 50% end points were determined and the sample titer were expressed in lU/ml in comparison with an international IFN standard.
Cell Mediated Lympholysis (CML) Assay Effector Cells: Single cell suspensions of effector cells were obtained from the mouse bulk MLR (120 hours). The collected cells were washed three times and cellular debris was removed by passing through nylon mesh. They were finally resuspended in RPMI1640 complete medium (-2ME).
Target Cells: Suspension culture of P815 mastocytoma (H-2d) cells maintained in RPMI1640 complete mediumwere washed twice and resuspended in serum free RPMI1640 medium.
51Cr Release Cytotoxic Assay : The test was performed in round-bottom microtiter plates (Linbro Chemical., New-Haven, CT, U.S.A.). P815 cells (4x lO6) in RPMI 1640 medium were incubated with 100 jbtCi of Na251CrO4 (specific activity 97 mCi/mg; JRIAm, Tokyo, Japan) for 60 minutes at 37°C. After washing three times, 1 x 104 target cells in 0.1 ml of RPMI 1640 complete medium (-2ME) were mixed with various concentrations of effector cells in 0.1 ml of complete medium (-2ME), to give effector to target ratios of 20:1, 10:1 and 5:1. After incubation for 4 hours at 37°C in CO2 incubator, supernatants were carefully collected from each well by a Titertek automatic harvesting system (Flow Laboratories, Rockville, MD, U.S.A.) and counted in a gamma counter.
Supernatants from wells containing target cells alone in 0.2 ml mediumserved as controls for the baseline release of 51Cr and 1 x 104 of 51Cr-labeled target cells were also counted to determine total 51Cr incorporated into the target cells.
The percentage of specific cytotoxicity was calculated as follows :
( %) Cytotoxicity = cpmof experimental group -cpm of mediumcontrol Determination of the Percent of Positive Cells: Six day MLRcells generated in the presence of immunosuppressants were incubated with CD25or fluorescence control IgGl (FITC). Fluorescence intensity profiles of experimental and control cells, normalized for total cell number, were superimposed, and the cross-over point was estimated. Areas under the curves to the right of the cross-over were determined and expressed as a percentage of total area. Control percentage area was subtracted from experimental yielding an estimate of the percent of positive cells.
Statistical
Analysis Results were analyzed for statistical significance by the Student's t-test.
Results
Suppression of Human MLRby FK-506
In our previous paper, we described the suppressive effect on mouse MLRby FK-506, CS and PRD. The IC50 values were 0.32 nM, 27 nMand 17 nM respectively.1} FK-506, CS and PRDwere tested for its ability to suppress the in vitro proliferative response of humanlymphocytes to alloantigen stimulation. The results of representative experiments in which various quantities of FK-506 and CS were added to the human MLRat the initiation of culture are illustrated in Fig. 1 The data are presented as the percentage of inhibition based on response in the control diluent. Effect of FK-506 on cfu-C The effect of FK-506, CS and PRDon the formation of granulocyte/macrophage colonies by murine bone marrow cells cultured with colony stimulating factors (CSF, L929 supernatants) in semisolid agar is shown in Fig. 3 . The IC50 values of FK-506, CS and PRDwere 1,400nM, 800nM and 140 nM, respectively. The growth and maturation of myeloid progenitor cells in vitro depends upon CSF, therefore FK-506 was non-toxic against myeloid progenitor cells approximately less than 1,000 nM.
FK-506 (a), CS (O) and PRD (à"
Suppression of FK-506 on the Generation of Cytolytic T Lymphocytes (CTL) Alloreactive CTL were generated from bulk MLRby mixing 5 x 106 C57BL/6 mouse lymphocytes with 5 x 106 mitomycin C-treated BALB/Cmouse lymphocytes. Various dilutions of FK-506, CS and PRDwere added to mouse bulk MLRat the initiation of culture. After a 5-day incubation, cells were washed and the cytotoxicity of the CTLwas determined by a short-term 51Cr-release micro-cytotoxicity assay by using P815 cells as targets.
As demonstrated in Table 1, FK-506 and CS significantly decreased the induction of CTL in a dose-dependent manner. The IC50 values of FK-506 and CS were 0.2 nM and 24 nM, respectively. PRD had negligible inhibitory on CTL generation and rather caused some enhancement at a high dose. A similar suppressive effect of FK-506 and CSwas observed in a different allogeneic system in which BALB/C mouse Ivmohocvtes were co- The data are expressed as inhibition % based on response in the control diluent. Meannumber of colonies/culture was 90.0±2.7 in control group. FK-506 (a), CS (O) and PRD (à") were added at the initiation of the culture. Table 3 . Effect of FK-506 and CS on IL-2 production of supernatants from human MLR.
Immunosuppress ants (nM) IL-2 production ; u/ml ( % inhibition) cultured with mitomycin C-treated C57BL/6 mouse lymphocytes for 5 days and the cytotoxicity of these effector cells was tested by using EL4 as targets.
Up to this point, it has been shown that the new agent, FK-506, suppressed the in vitro proliferative response of lymphocytes to alloantigen stimulation and cytotoxic T cell generation at about hundred times lower concentration than did CS and was shown that this agent was as non-toxic as CS. Then, we investigated the effect of FK-506 on the production of T cell-derived soluble mediators, such as IL-2, IL-3 and IFN-f induced by alloantigen.
Suppression of IL-2 Production from Mouse and HumanMLRby FK-506
Weinvestigated the effect of non-toxic concentrations of FK-506 and CS on the production of Table 2 for mouseexperiments  and Table 3 for human experiments. In both experiments IC50 values of FK-506 and CS were approximately 0.1 nMand 10 nM, respectively.
Suppression of IL-3 Production from
Mouse MLRby FK-506 In the same way, wetested the supernatants of mouse bulk MLRfor IL-3 activity using the IL-3 dependent FDC-P2 cell line.
The results of representative experiment are shown in Table   4 . IC50 values of FK-506 and CS were approximately 0.3 nM and 32 nM, respectively. Suppression of IFN-f Production from Mouse MLRby FK-506 In the same way, we tested the supernatants of mouse bulk MLRfor IFN-f activity using the dye uptake method of L929-VSVsystem. The results of representative experiment are shown in Table  5 . IC50 values of FK-506 and CS in suppression of IFN-f production from mouse MLRwere approximately 0.1 nM and 3.2 nM, respectively.
Suppression of IL-2 Receptor Expression in Human MLRby FK-506
The 6-day human MLRswere established by using normal human PBL. Graded dilutions of FK-506 or CS were added to the bulk lymphocytes at the initiation of the culture. Cultivated live cells determined by the exclusion of PI were then analyzed on a FACSAnalyzer. IL-2 receptor expression in the human MLRwas determined by the percent of Tac positive cells. As shown in Fig. 4 , and CS inhibited the expression of IL-2 receptor on lymphocytes. The IC50 values of FK-506 and CS were approximately 0.1 nM and 10 nM, respectively. Discussion CS has been used successfully as the primary drug to suppress the rejection of transplants.2>3) However, its specific immunosuppressive effect on the one hand, and clinical nephrotoxicity on the other, have led us to search for more specific and less toxic newimmunosuppressants. FK-506 was discovered in 1984 in our laboratories during a search for immunosuppressive substances amongnatural products. This agent was isolated from the fermentation broth of a strain of StreptomycesP The data obtained from the present experiments show that the new immunosuppressant, FK-506, strongly inhibited the proliferative response of lymphocytes to alloantigen stimulation, the cytotoxic T cell generation, the expression of IL-2 receptor and the production of T cell derived soluble mediators such as IL-2, IL-3 and IFN-r at non-toxic concentrations. Further, it was shown that the new agent suppressed at about hundred times lower concentration than did CS in all tests. The toxic concentration of this agent against T lymphoma is more than 10"6 m ( Figs. 2 and 3 ) and the effective concentration of immunosuppression is about 10"10 m. Meanwhile, the former of CS is more than 10"6 m and the latter is about 10"8 m. The immunosuppressive effect of FK-506 has a high degree of selectivity.
The MLRand the assay of CTLused here are generally regarded in vitro correlates of allograft rejection.12) FK-506 inhibited both mouse and human MLR. FK-506 also inhibited mouse CTL generation. Accordingly, FK-506 is an effective immunosuppressant that may prove useful in organ transplantation.
Glucocorticosteroids exert complex, and generally suppressive effects on lymphocytes and on immune responses. In particular, it has been found that glucocorticosteroids inhibit mitogen-or antigen-induced T cell proliferation.^In our experiments, PRDsuppressed antigen induced mouse and human T cell proliferation.
( Fig. 1 ) However, PRD strongly inhibited BW5147 cell's growth and cfu-C. (Figs. 2 and 3) The immunosuppressive effect of PRDis less specific than FK-506 and CS. The suppression on cfu-C of PRDmaycause to depress myelopoiesis and erythropoiesis, meanwhile, FK-506 and CS may not. Furthermore, PRDhad negligible effects on CTL generation and enhanced at high dose. (Table 1) The mode of action of FK-506 and CS is different from that of PRDand seems to be more specific suppression on the proliferative response of lymphocytesto alloantigen stimulation, the cytotoxic T cell generation. The immunosuppressive effects of CS may be based, at least in part, on its ability to inhibit production of the lymphokines by T lymphocytes, especially IL-2 or expression of IL-2 receptor.4*^FK-506 also suppressed at about hundred times lower concentration than CS on the production of lymphokines and the expression of IL-2 receptor. Though the cascade and the action of lymphokines are still unclear, it may prevent the clonal expansion of T cells and the cytotoxic T cell generation with the inhibition on the production of lymphokines by T lymphocytes, especially IL-2 or the expression of IL-2 receptor.
In certain conditions, IL-2 is required for the production of IFN-^,13) and IFN-7% in turn, induces the expression of IL-2 receptors.14) These lymphokines are also involved in differentiation and activation of cytotoxic effects of CML?15) so they are likely to play a role in organ transplant rejection and acceptance. IL-3 can promote the growth of certain lymphocytes that are not IL-2 dependent, and it may be a suppressor cell growth, activation, or maturation factor.163 FK-506 and CS required slightly higher concentration than IL-2 and IFN-7 to suppress the production of IL-3 (Table 4) , so FK-506 and CStherapy maysemi-selectively spare suppressor cells. Though the modeof action of FK-506 remains unclear, it should provide a valuable tool for investigating the immunological actions of lymphokines.
